More than a year after the FDA yanked away authorization from Evusheld, a monoclonal antibody treatment for COVID-19, the agency granted emergency use authorization to a new COVID-19 preventive drug March 22.
Paige Twenter is a reporter for Becker's Healthcare, focusing on national healthcare news in the United States. With a keen interest in supply chain management, hospital operations, and healthcare policy, Paige covers a range of topics including supplier diversity, medical shortages, sepsis prevention, and the impact of technology on healthcare delivery.